InsidersTradesSigma
Track the 셀로맥스사이언스 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 셀로맥스사이언스 has recorded 3 insider filings. Market capitalisation: €45.4bn. The latest transaction was disclosed on 6 April 2026 (Purchase). Among the most active insiders: 서지완. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
Cellomax Science is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in developing innovative solutions for the medical field.